Article
Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine.
BMC microbiology - 29 Apr 2014
Tzanakaki Georgina, Hong Eva, Kesanopoulos Konstatinos, Xirogianni Athanasia, Bambini Stefania, Orlandi Luca, Comanducci Maurizio, Muzzi Alessandro, Taha Muhamed-Kheir
Abstract excerpt
BACKGROUND: Serogroup B meningococcal (MenB) isolates currently account for approximately 90% of invasive meningococcal disease (IMD) in Greece with ST-162 clonal complex predominating. The potential of a multicomponent meningococcal B vaccine (4CMenB) recently licensed in Europe was investigated in order to find whether the aforementioned vaccine will cover the MenB strains circulating in Greece. A panel of 148...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
